Outlook Therapeutics Inc (OTLK)

[H2R]

Hi Termo,

That's how I see it too. The long term value is still at play, provided the Company can address the issues.

What I heard in the Webcast yesterday could be set up a two parts issues:
* CMC issues, which they seem to think should be addressable / clarification, new questions. (I was a bit surprised at that given the previous CRLs and inspections)
* The substantial evidence. That's the one I would like to have some real definition, so would the Company.

As you write, the Type A meeting outcome will hopefully let us know.

As far as money lost, we make our decisions based on the info we have. If I lose money, I'm not going to point fingers. I've been an adult for long enough :)
The top line data was superb, the market opportunity is there.

And I, as many others I believe, do appreciate your insights.

Cheers!